Literature DB >> 16919804

Impact of surgeon specialty on ovarian-conserving surgery in young females with an adnexal mass.

Robert E Bristow1, Andrea C Nugent, Marianna L Zahurak, Victor Khouzhami, Harold E Fox.   

Abstract

PURPOSE: To evaluate the patterns of surgical care among pediatric and adolescent females undergoing operative intervention for an adnexal mass with particular attention toward factors associated with ovarian-conserving surgery and access to gynecologic care.
METHODS: All female patients aged < or = 18 years undergoing surgery for an adnexal mass between January 1, 1991 and December 31, 2002 were retrospectively identified and demographic, operative, and pathologic data abstracted. Logistic regression analyses were used to identify factors independently associated with ovarian-conserving surgery and access to gynecologic care.
RESULTS: Eighty-two consecutive cases were identified. The median age at surgery was 15 years, and 91.7% of patients were > or = 12 years of age. A malignant ovarian neoplasm was present in 14.6% of cases. Oophorectomy was performed in 52.4% of cases, while 47.6% of patients underwent ovarian-conserving surgery. Multivariate regression analysis revealed that ovarian-conserving surgery was significantly less likely in the setting of malignancy, torsion, and an ovarian size of > or = 6 cm. The presence of a gynecologic surgeon, compared to other surgical specialties, was statistically significantly and independently associated with ovarian-conserving surgery (odds ratio [OR] 8.71, 95% confidence interval [CI] 2.12-41.41, p = .001). Post-menarchal status and age > or = 16 years were the characteristic most predictive of access to gynecologic surgical care.
CONCLUSIONS: In pediatric and adolescent patients, operative intervention for an adnexal mass is significantly more likely to result in ovarian conservation when performed by a gynecologic surgeon. For such patients, improved access to gynecologic consultation prior to surgical intervention may reduce the number of patients subjected to oophorectomy for benign conditions.

Entities:  

Mesh:

Year:  2006        PMID: 16919804     DOI: 10.1016/j.jadohealth.2005.12.022

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  7 in total

1.  Compensatory Ovarian Hypertrophy after Unilateral Oophorectomy: Evaluation of Ovarian Volumes in Pediatric and Adolescent Populations.

Authors:  Allison C Mayhew; James Bost; Leann Linam; Sarah Milla; Mina Farahzad; Krista J Childress
Journal:  J Pediatr Adolesc Gynecol       Date:  2020-07-18       Impact factor: 1.814

2.  Mucinous Cystadenoma in Children and Adolescents.

Authors:  Renee A Cowan; Erin N Haber; Fabio R Faucz; Constantine A Stratakis; Veronica Gomez-Lobo
Journal:  J Pediatr Adolesc Gynecol       Date:  2017-02-16       Impact factor: 1.814

3.  Pelvic Inflammatory Disease: Possible Catches and Correct Management in Young Women.

Authors:  Chiara Di Tucci; Daniele Di Mascio; Michele Carlo Schiavi; Giorgia Perniola; Ludovico Muzii; Pierluigi Benedetti Panici
Journal:  Case Rep Obstet Gynecol       Date:  2018-07-11

4.  Ovarian Torsion: Presentation and Management in a Pediatric Patient.

Authors:  Katie P Nguyen; William L Valentino; Duy Bui; Honey Milestone
Journal:  Case Rep Obstet Gynecol       Date:  2022-02-22

5.  Ovarian neoplasia in adolescence: a retrospective chart review of girls with neoplastic ovarian tumors in Saudi Arabia.

Authors:  Lateefa AlDakhil; Asma Aljuhaimi; Mashael AlKhattabi; Saleh Alobaid; Rafif E Mattar; Abdulaziz Alobaid
Journal:  J Ovarian Res       Date:  2022-09-16       Impact factor: 5.506

6.  Selecting treatment method for ovarian masses in children - 24 years of experience.

Authors:  Justyna Łuczak; Maciej Bagłaj
Journal:  J Ovarian Res       Date:  2017-09-11       Impact factor: 4.234

7.  Missed opportunities for ovarian salvage in children: an 8-year review of surgically managed ovarian lesions at a tertiary pediatric surgery centre.

Authors:  D Karavadara; J R Davidson; L Story; Y Diab; M Upadhyaya
Journal:  Pediatr Surg Int       Date:  2021-07-07       Impact factor: 1.827

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.